Mu-Tzu Chu

Ms. Mu-Tzu Chu

Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan
orcid

Biography

Dr. Chu graduated from the Institute of Pharmacology, National Yang Ming Chiao Tung University. Her PhD studies mainly focused on the immune pathomechanism of drug hypersensitivity. She is a post-doc working in the Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Taiwan. The followings are her publications. 1. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2021 Jun;141(6):1461-1472.e10. 2. Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nat Commun. 2019 Aug 8;10(1):3569. 3. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. J Immunol Res. 2018 Dec 19;2018:4325874. 4. Rhein, An Anthraquinone Drug, Suppresses the NLRP3 Inflammasome and Macrophage Activation in Urate Crystal-Induced Gouty Inflammation. Am J Chin Med. 2019;47(1):135-151. 5. Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2015 Sep;135(9):2237-2248.

Affiliations

Linkou Chang Gung Memorial Hospital

Taoyuan City, Taiwan

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.